Hydrogen sulfide (H 2 S) is an endogenous gaseous mediator of mucosal defense with antiinflammatory effects that promote ulcer healing. The effects of H 2 S during the pathogenesis of colitis have not been established. We analyzed the contribution of H 2 S to inflammation and ulceration of the colon in a rat model of colitis. METHODS: Colitis was induced by intracolonic administration of trinitrobenzene sulfonic acid. The ability of the colon to synthesize H 2 S was studied over the course of the resolution of the colitis. Expression of 2 enzymes involved in the synthesis of H 2 S and the effects of inhibitors of these enzymes were examined. We also examined the effects of H 2 S donors on the resolution of colitis. RESULTS: The capacity for the colon to produce H 2 S increased markedly over the first days after induction of colitis and then declined toward control levels as the colitis was resolved. Inhibition of colonic H 2 S synthesis markedly exacerbated the colitis, resulting in significant mortality. Inhibition of H 2 S synthesis in healthy rats resulted in inflammation and mucosal injury in the small intestine and colon along with down-regulation of cyclooxygenase-2 messenger RNA expression and prostaglandin synthesis. Intracolonic administration of H 2 S donors significantly reduced the severity of colitis and reduced colonic expression of messenger RNA for the proinflammatory cytokine tumor necrosis factor ␣. CONCLUSIONS: In rats, H 2 S modulates physiological inflammation and contributes to the resolution of colitis.
H ydrogen sulfide (H 2 S), although often regarded mainly as a toxin and industrial pollutant, is produced throughout the body, with normal plasma concentrations being in the 30 to 100 mol/L range. 1,2 H 2 S has recently been identified as an endogenous vasodilator, neuromodulator, and antiinflammatory mediator. [1] [2] [3] [4] [5] It contributes significantly to gastric mucosal defense, 6 promotes the healing of gastric ulcers in rodents, 7 and has been implicated as a regulator of intestinal secretion in guinea pigs. 8 Two of the key enzymes for synthesis of H 2 S have been identified in the colon of guinea pigs and humans (expressed in Ͼ90% of submucous and myenteric neurons 8 ) and in the stomach and small intestine of rodents. 6 These findings all suggest important physiologic and pathophysiologic roles of H 2 S in the gastrointestinal tract.
Concentrations of H 2 S in the lumen of the colon have been reported to be extremely high relative to physiologic concentrations in the body. 9, 10 However, there is disagreement as to whether or not the concentrations of free H 2 S really reach the millimolar range that has been reported. 11 A specific role of H 2 S in the context of inflammatory bowel disease (IBD) has been suggested, 12 but there are diametrically opposed views of this role. On the one hand, there have been suggestions for many years that high levels of H 2 S produced in the lumen of the colon by bacteria could contribute to colitis and possibly to colon cancer. [12] [13] [14] It has been suggested that luminal H 2 S may impair oxidation of n-butyrate by colonocytes and that this could lead to impaired barrier function and thereby contribute to the pathogenesis of ulcerative colitis. 15 However, this specific effect of H 2 S has been challenged, 16 as has the potential contribution of H 2 S to the pathogenesis of ulcerative colitis. 17, 18 Indeed, there is a lack of compelling evidence that H 2 S causes damage to colonic epithelial cells; rather, colonocytes appear to be particularly well adapted to utilize H 2 S as a metabolic fuel. 19 Moreover, a beneficial effect of H 2 S in the context of colitis was suggested by the recent demonstration of markedly improved antiinflammatory activity of a H 2 S-releasing derivative of mesalamine in experimental colitis. 20 Unlike mesalamine, the H 2 S-releasing mesalamine derivative significantly reduced colonic expression of several proinflammatory cytokines (eg, tumor necrosis factor [TNF]-␣, interferon [IFN]-␥ 20 ) , possibly a consequence of the reported ability of H 2 S to inhibit activation of nuclear transcription factor (NF)-B. 21, 22 In rats, H 2 S donors were recently shown to significantly inhibit leukocyte adherence to the vascular endothelium, extravasation of leukocytes in response to zymosan, and paw edema induced by carrageenan. 3 Moreover, endogenous H 2 S appears to play a significant role in modulating inflammatory reactions, as indicated by the exacerbation of acute inflammatory reactions when inhibitors of H 2 S were administered to rats. 3 The present study was performed to delineate better the possible role of H 2 S in experimental colitis. The trinitrobenzene sulfonic acid (TNBS) model of colitis in rats 23, 24 is very well suited for this study because one can examine tissues immediately before and at defined times after induction of colitis and because the course of resolution of colitis in this model has been well characterized. [23] [24] [25] Colonic H 2 S synthesis was measured over the course of a bout of colitis, as was expression of 2 key enzymes for H 2 S synthesis. We then examined the effects of inhibitors of H 2 S synthesis and of H 2 S donors on the severity of colitis. Our findings point to an important contribution of endogenous H 2 S to the resolution of colitis and suggest that this process can be accelerated via administration of exogenous H 2 S. Moreover, administration to healthy rats of an inhibitor of endogenous H 2 S synthesis led to significant colonic inflammation.
Materials and Methods Animals
Male Wistar rats (200 -225 g) were fed standard laboratory chow and water ad libitum. They were housed in plastic cages in a room with controlled temperature (22°C Ϯ 1°C), humidity (65%-70%), and light cycle (12 hours:12 hours light-dark). All experiments were conducted in accordance with the guidelines established by the Canadian Council of Animal Care, and the protocols have been approved by the Animal Care Committee at the University of Calgary. Colitis was induced via intracolonic administration of TNBS (45 mg/mL in 0.5 mL of 40% ethanol). 23, 24 
H 2 S Synthesis
The principal pathways for H 2 S synthesis in mammals involve conversion of L-cysteine to pyruvate, ammonium, and H 2 S via either of 2 pyroxidal-5'-phosphatedependent enzymes: cystathionine-␥-lyase (CSE) and cystationine-␤-synthase (CBS). 1 Groups of rats (n Ն 6) were killed 6 hours to 28 days after TNBS administration for determination of H 2 S synthesis and expression of CSE and CBS. The severity of colitis was scored using a system described in detail previously, 19 which takes into consideration the presence and extent of inflammation and ulceration. Samples of the colon (full thickness) were taken from a region 3-4 cm proximal to the rectum. The samples were snap frozen in liquid nitrogen and stored at Ϫ80°C until the H 2 S assay was performed. The method for measuring colonic synthesis of H 2 S is modified slightly 7 from that described by Qu et al. 26 The standard curve for this spectrophotometric assay was constructed using various concentrations of NaHS. 26 
CBS and CSE Expression
Western blot analysis was used to determine colonic expression of CBS and CSE in samples of colon from rats with colitis and healthy controls. 7 The expression of CSE and CBS in a sample was normalized to the expression of ␤-actin. Immunohistochemical analysis of CSE and CBS expression was performed by routine techniques using paraffin-embedded samples of colon. Mouse monoclonal anti-CSE and anti-CBS antibodies (ABNOVA, Taipei, Taiwan) were used.
Effects of Inhibitors of Endogenous H 2 S Synthesis
Effects of inhibitors of CBS and CSE were tested in vitro in the H 2 S synthesis assay, using colonic tissue harvested from healthy controls and from rats with colitis (72 hours post-TNBS administration). We examined the effects of 2 inhibitors of CSE (␤-cyanoalanine [BCA], 3 mmol/L; and propargylglycine [PAG], 3 mmol/L) and 1 inhibitor of CBS (O-carboxymethyl-hydroxylamine hemihydrochloride [CHH], 3 mmol/L). These concentrations of the drugs were selected based on pilot studies performed in our laboratory using rat colon. PAG and BCA differ in their mechanisms of inhibition of CSE, the former being an irreversible inhibitor and the latter a reversible inhibitor. 27, 28 Additional in vitro studies were performed in which the effects on H 2 S synthesis of a combination of PAG and CHH were evaluated in samples taken at various times after induction of colitis (6 and 24 hours, and 3 and 7 days after TNBS administration).
We then performed in vivo studies in which groups of rats (n Ն 12) that had been given TNBS intracolonically to induce colitis or healthy controls were treated twice daily, intraperitoneally (IP), with 1 of the H 2 S synthesis inhibitors for 7 days (BCA and PAG at 50 mg/kg, CHH at 20 mg/kg). Rats that survived until either day 7 or day 14 post-TNBS administration were killed, and the severity of colitis was blindly evaluated. 19 Samples of colonic tissue were processed by routine techniques for histologic examination and for determination of myeloperoxidase (MPO) activity as a marker of granulocyte infiltration into the tissue. 29, 30 Role of Adenosine Triphosphate-Sensitive K ؉ Channels Some actions of H 2 S are mediated, at least to some extent, via activation of adenosine triphosphate (ATP)-sensitive K ϩ (K ϩ ATP ) channels. 31 Experiments were performed as described above, but the treatments included either an agonist of K ϩ ATP (pinacidil, 10 mg/kg, IP) or an antagonist of these channels (glibenclamide, 10 mg/kg, IP).
Effects of H 2 S Donors
Starting 1 hour after TNBS administration, groups of rats (n Ն 6) were treated twice daily, intracolonically, with an H 2 S donor (NaHS, 30 mol/kg; or Lawesson's reagent, 30 mol/kg) or vehicle for a total of 4 days. The selection of doses of the H 2 S donors was based on our prior experience with these drugs. 3, 7 The rats were killed 2 hours after the final dose, and the severity of colitis was blindly evaluated. 19 The thickness of the colon was measured with digital calipers. Samples of colonic tissue were processed for histology and for determination of expression of messenger RNA (mRNA) for TNF-␣, COX-1, and COX-2 mRNA (see below). Additional samples were processed, as described previously, for determination of colonic prostaglandin E 2 synthesis 32 and TNF-␣ protein levels 33 by enzyme-linked immunosorbent assay (ELISA) (Cayman Chemical Ltd., Ann Arbor, MI, and R&D Systems, Minneapolis, MN, respectively).
Real-time Reverse Transcription Polymerase Chain Reaction
Samples of distal colonic tissue were excised, snap frozen in liquid nitrogen, and stored at Ϫ80°C until required for processing. RNA extraction was performed using the RNeasy Kit (Qiagen, Valencia, CA) according to manufacturer's instructions. For gene expression studies, 2-step real-time reverse transcription polymerase chain reaction was utilized, as described previously. 34 
Statistical Analysis
All data are expressed as the mean Ϯ SEM. Groups of data were compared using a 1-way analysis of variance followed by the Dunnett multiple comparison test, or by the Mann-Whitney U test, where appropriate. A Gehan-Breslow-Wilcoxon test was used for comparisons of survival data. An associated probability (P value) of less than 5% was considered significant.
Results

Colonic H 2 S Synthetic Capacity Is Markedly Elevated After Induction of Colitis
The synthesis of H 2 S from endogenous substrate did not differ between samples that were taken from healthy rats and those taken from rats with colitis ( Figure  1A ). With samples from healthy controls, addition to the homogenate of exogenous L-cysteine did not significantly alter H 2 S synthesis. However, when samples of inflamed colon were incubated with exogenous L-cysteine ( Figure  1C) , very large increases (Ͼ100-fold) in H 2 S synthesis were observed. By 28 days after TNBS administration, when the colitis was largely resolved (Figure 1B ), H 2 S synthesis had returned to control levels ( Figure 1C ).
CBS and CSE Contribute to Colonic H 2 S Synthesis During Colitis
The elevated capacity of inflamed colon to synthesize H 2 S occurred via the enzymes CSE and CBS. The combination of inhibitors of these 2 enzymes reduced H 2 S synthesis by healthy colonic tissue by ϳ50% ( Figure  2 ), whereas that by colonic tissue from rats with colitis was reduced by 75%-98% by the 2 inhibitors, at all time points.
CBS appears to be the major source of H 2 S synthesis in both healthy and inflamed colon (Figure 3 ). The CBS inhibitor (CHH) reduced H 2 S synthesis by healthy colon by ϳ50%, whereas neither of the CSE inhibitors (BCA and PAG) had an effect. In the case of inflamed colon, the shows the severity of colitis over the course of 28 days. In the absence of added substrate, there were no significant differences in H 2 S synthesis by the inflamed colon as compared with the normal colon. However, when samples of inflamed colon were incubated with L-cysteine (10 mmol/L), significant increases in H 2 S synthesis were observed (ie, there was a marked increase in the capacity for converting L-cysteine to H 2 S). *P Ͻ .05, ***P Ͻ .001 vs controls.
CBS inhibitor reduced H 2 S synthesis by approximately 75%.
CSE and CBS Expression
Despite the observation of a marked increase in the capacity of inflamed colon to synthesize H 2 S, and the pharmacological evidence that this increase was largely due to synthesis via CBS, we observed an apparent downregulation of the expression of CSE and CBS at some points when colonic injury and inflammation were substantial (Supplementary Figure 1) . CBS expression was normal at 6 and 24 hours after TNBS administration, reduced at 3 and 7 days, and significantly elevated at 28 days. CSE expression was significantly lower at most time points. These data, together with the above-described evidence of a very large increase in the capacity of colonic tissue to generate H 2 S from exogenous L-cysteine, suggest that changes in enzyme activity, rather than expression, accounted for the elevated H 2 S production in this model of colitis.
Immunohistochemical staining of colonic tissue was not entirely consistent with the data from Western blotting. Expression of CBS was mainly evident in the muscularis mucosae and submucosa ( Figure 4A-4C) . As compared with controls ( Figure 4A ), CBS staining was diminished at 24 hours ( Figure 4B ) but more widespread at 7 days post-TNBS administration ( Figure 4C ). CSE staining was concentrated around blood vessels in the mucosa and submucosa ( Figure 4D-4F ). There was diminished staining at 24 hours ( Figure 4E ), but more extensive staining at 7 days post-TNBS administration (some of which appeared to be around sites of angiogenesis; Figure 4F ). Goblet, crypt, and epithelial cells were immunonegative for CSE and CBS.
Inhibition of H 2 S Synthesis Exacerbates Colitis
Having established that H 2 S synthesis by the inflamed mucosa could be markedly reduced by treatment with a CBS inhibitor and to a lesser extent by 1 of the CSE inhibitors, we examined the effects on colitis of twice-daily administration of inhibitors over a 1-week period. As shown in Figure 5 , there was substantial mortality observed in the groups of rats treated with each of the inhibitors, but particularly with CHH and PAG (note that PAG, unlike BCA, is an irreversible inhibitor of CSE 27 ). Indeed, none of the rats treated with CHH or PAG survived until the predefined end point of the study. In rats treated with BCA that survived until the end of the experiment, there was a significant increase in severity of colonic damage and in the thickness of the colon ( Figure 6 ). The increase in the thickness of the colon in BCA-treated rats was mainly attributable to submucosal edema and hypertrophy of the muscularis (Figure 7A and 7B).
Inhibition of H 2 S Synthesis Triggers Colonic Inflammation
It is possible that the high mortality observed in the rats with colitis that had been treated with CHH or PAG was due to exacerbation of colitis or perhaps unrelated to the colitis altogether. To determine whether suppression of H 2 S synthesis in healthy rats resulted in death or elicited significant changes in the gastrointestinal tract, healthy rats were treated with CHH, PAG, or BCA (n ϭ 4 -6 per group) in the same manner as the rats with colitis had been treated. All rats treated with BCA twice daily for a week survived. Weight gain was the same in these groups (57 Ϯ 2 g and 59 Ϯ 4 g over 7 days, respectively). However, the small intestine and colon of the rats treated with BCA were inflamed and friable. Colonic MPO activity was significantly increased in BCA- Figure 3 . The enzymatic sources of colonic H 2 S synthesis were examined in healthy rats and rats killed 72 hours after induction of colitis. ␤-cyanoalanine (BCA) and propargylglycine (PAG) are inhibitors of cystathionine-␥-lyase, whereas O-carboxymethyl-hydroxylamine hemihydrochloride (CHH) is an inhibitor of cystathionine-␤-synthase. Each inhibitor was tested at 3 mmol/L, and the substrate for H 2 S synthesis (L-cysteine) was present at 4 mmol/L. Only CHH significantly reduced H 2 S synthesis in tissue from healthy controls. In samples from rats with colitis, CHH reduced H 2 S synthesis by 75%, whereas BCA reduced H 2 S synthesis by 41%. *P Ͻ .05, ***P Ͻ .001 compared with corresponding controls. treated rats (4.9 Ϯ 0.1 U/mg vs 3.6 Ϯ 0.3 U/mg in vehicle-treated rats; P Ͻ .05). Treatment with BCA had no effect on colonic expression of mRNA for TNF-␣ (foldchange: 1.00 Ϯ 0.08 in controls vs 1.25 Ϯ 0.16 in BCAtreated), or COX-1 (fold-change: 1.00 Ϯ 0.05 in controls vs 1.06 Ϯ 0.05 in BCA-treated), but there was a significant decrease (Ͼ2-fold) in expression of COX-2 mRNA (foldchange: 1.00 Ϯ 0.09 in controls vs Ϫ1.16 Ϯ 0.13 with BCA; P Ͻ .05). A significant reduction (ϳ50%) in colonic PGE 2 synthesis was also observed in the rats treated with BCA (45.1 Ϯ 8.3 pg/mg vs 109.5 Ϯ 11.1 pg/mg in healthy controls; P Ͻ .05). Treatment of healthy rats with PAG or CHH resulted in significant mortality (50% and 100%, respectively). In the case of CHH, the mortality in healthy rats occurred later (on days 3 or 4 of treatment) than that observed in rats with colitis (days 1 or 2 of treatment). In the rats that survived treatment with PAG, the small intestine and colon were hyperemic, atrophic, and friable. The mean colonic MPO activity was 6.3 U/mg (n ϭ 2; the mean MPO in vehicle-treated rats was 3.6 Ϯ 0.3 U/mg). As was the case with BCA, there was a marked downregulation of cyclooxygenase (COX)-2 mRNA expression and prostaglandin E 2 synthesis (ϳ50% of control levels) in the colon of surviving PAG-treated rats.
Role of ATP-sensitive K ؉ Channels
Treatment of rats with colitis with an antagonist of K ϩ ATP channels, glibenclamide, resulted in significant mortality ( Figure 5 ). Within 2 days of initiating the twice-daily treatment with glibenclamide, 80% of the rats had died. In contrast, no mortality occurred in rats with colitis that were treated with pinacidil, a K ϩ ATP agonist. Pinacidil treatment did not affect the severity of colitis (after 1 week of treatment, damage scores of 13.4 Ϯ 1.6 vs 11.5 Ϯ 1.9 in controls; colonic MPO of 84 Ϯ 13 U/mg vs 128 Ϯ 22 in controls).
Healthy rats treated twice daily for a week with either pinacidil or glibenclamide were indistinguishable from vehicle-treated rats in terms of macroscopic appearance of the gastrointestinal tract. No deaths occurred, and the weight gain over a week of treatment with glibenclamide (55 Ϯ 2 g) or pinacidil (60 Ϯ 3 g) did not differ significantly from that of healthy rats treated with vehicle (59 Ϯ 4 g).
H 2 S Donors Reduced the Severity of Colitis
Twice-daily treatment by enema with either of 2 H 2 S donors (NaHS and Lawesson's reagent) resulted in a significant reduction in the severity of colitis (Figure 8 ). In addition to the colonic damage scores being significantly reduced as compared with the vehicle-treated group, both of the H 2 S donors significantly attenuated the increase in colonic thickness that occurs in rats with colitis. However, there was no effect of the H 2 S donors on MPO activity in the distal colon of the rats (vehicle: 129 Ϯ 13 U/mg; NaHs: 87 Ϯ 17 U/mg; Lawesson's: 118 Ϯ 9 U/mg), and histologic evaluation confirmed that there was extensive infiltration of the tissue with granulocytes (mainly neutrophils).
In vehicle-treated rats, there was a substantial up-regulation of the expression of TNF-␣ and COX-2 (ϳ7-fold and ϳ30-fold over healthy controls, respectively) but no significant change in COX-1 expression. Treatment with either of the 2 H 2 S donors significantly reduced TNF-␣ expression (Figure 8 ) but did not affect COX-1 or COX-2 expression. When colonic levels of TNF-␣ protein were examined, a significant reduction (50%) was observed in the group treated with NaHS (12.6 ϩ 3.5 pg/mg protein vs 6.5 ϩ 1.6 pg/mg protein, respectively; P Ͻ .05). In the group treated with Lawesson's reagent, there was considerable variability in the data, with no significant difference from the control group.
Discussion
H 2 S is produced throughout the body, and there is growing evidence that it plays an important role in numerous physiological and pathophysiological processes. 4, 35 In the present study, we have observed that H 2 S synthesis by the colon of the rat increases dramatically (ϳ100-fold) after induction of colitis, returning to control levels as the inflammation resolves. The primary enzymatic source Figure 6 . Effects of twice-daily treatment with an inhibitor of cystathionine-␥-lyase (␤-cyanolalanine [BCA]; 50 mg/kg) for 1 week on (A) severity of colitis and (B) thickness of the colonic wall. The rats were killed 14 days after TNBS administration. In panel B, the dashed line indicates mean thickness of the colonic wall in healthy rats. **P Ͻ .01 vs the vehicle-treated group (n ϭ 9 in the vehicle-treated group) and 6 in the BCA-treated group. of H 2 S in this context is CBS, but CSE also makes an important contribution. Inhibition of H 2 S synthesis resulted in exacerbation of colitis and to significant mortality (which does not appear to be entirely attributed to effects of the inhibitors on the colon). Moreover, inhibition of H 2 S synthesis in healthy rats led to significant intestinal inflammation and loss of mucosal integrity, as well as a down-regulation of expression of COX-2 mRNA. Administration of either of 2 H 2 S donors significantly reduced the severity of colitis, as well as mucosal TNF-␣ mRNA expression. Taken together, these findings suggest that H 2 S contributes to the resolution of colitis and is an endogenous antiinflammatory mediator in the colon.
Schicho et al 8 demonstrated expression of CSE and CBS in the enteric nervous system of the guinea pig and human intestine. In the present study, we detected expression of both of these enzymes in the rat colon; CBS staining was not apparent in the epithelium but was in the lamina propria consistent with the observations with Schicho et al. The staining for CSE was quite diffuse, consistent with previous reports that this enzyme is expressed within vascular elements, 35 as well as with the report of Schicho et al that CSE is expressed in over 90% of submucous and myenteric nerves. 8 It is interesting that CBS was, at least based on the effects of inhibitors, the major source of colonic H 2 S, both in the healthy state and when inflamed.
H 2 S produces a wide variety of effects that may contribute to its ability to modulate colitis. 35 It can inhibit leukocyte adherence to the endothelium and reduce edema formation 3 ; suppress the expression of several proinflammatory cytokines and enzymes, such as TNF-␣, IFN-␥, and iNOS 22, 32 ; act as an antioxidant 36 ; and promote healing. 7 At least some of these effects may be related to inhibition of activation of NF-B. 21, 22 In the present study, we observed a significant down-regulation of expression of mRNA for TNF-␣ in rats with colitis treated with H 2 S donors (and in the case of NaHS, a significant reduction of TNF-␣ protein in the colon). Previously, a garlic-derived substance that releases H 2 S (allyl trisulfide) 37 was shown to suppress TNF-␣ expression and NF-B activation in colonic biopsy samples from ulcerative colitis patients. 38 We also observed that an inhibitor of H 2 S synthesis markedly down-regulated colonic COX-2 activity, and this was accompanied by reduced colonic prostaglandin E 2 synthesis and induction of inflammation in the tissue. COX-2 is a source of several antiinflammatory eicosanoids and plays a crucial role in the resolution of inflammation in many tissues, 39 -41 including the gastrointestinal tract. Indeed, COX-2 plays a crucial role in the resolution of TNBSinduced colitis in rats, 42 including being a source of important antiinflammatory mediators (eg, prostaglandin D 2 ). 25, 43 Several actions of H 2 S, including vasodilation, inhibition of leukocyte adherence, and visceral analgesia, have ; 50 mg/kg). These samples were taken from rats that were included in the data presented in Figure 6 . The thickness of the mucosa is similar in the 2 sections, but, in the BCA-treated rat, there is submucosal edema and profound hyperplasia of the muscularis mucosae and the muscularis propria. The 2 micrographs were taken at the same magnification. been suggested to be mediated via activation of K ϩ ATP channels. 3, 5, 31 In the present study, administration of pinacidil, an agonist of K ϩ ATP channels, did not confer any beneficial effects. On the other hand, treatment with glibenclamide, an antagonist of K ϩ ATP channels, led to significant mortality in rats with colitis. This appears to have been due to a worsening of the colitis, rather than a nonspecific toxicity of glibenclamide, because no mortality or weight loss was observed when healthy rats were similarly treated. Thus, it is possible that activation of K ϩ ATP channels by endogenous H 2 S contributes to its ability to attenuate the severity of colitis.
The question of whether H 2 S is beneficial vs detrimental to the colon has been controversial for many years. Some have suggested that the H 2 S produced in the lumen of the colon may contribute to the pathogenesis of ulcerative colitis and/or colon cancer. [12] [13] [14] [15] There certainly appears to be at least as much data countering this claim as there are supporting it, and questions have been raised as to the accuracy of some estimates of very high concentrations of H 2 S in the lumen. 16 -18,44,45 Most of the H 2 S that is produced in the lumen of the intestine is absorbed and rapidly metabolized. 46 Indeed, efficient detoxification occurs via a number of enzymes present in the mucosa, 17 and no impairment of these detoxification systems was detected in patients with ulcerative colitis or Crohn's disease. Based on studies utilizing a rat model of colitis (dextran sodium sulfate), Furne et al 47 concluded that "excessive H 2 S production" did not contribute to tissue injury. The results from the present study point to a predominantly positive role for endogenous H 2 S (ie, that produced by the colon itself). Moreover, a garlicderived product (garlicin) that can release H 2 S was shown to reduce the severity of TNBS-induced colitis in rats. 48 The observation that treatment of healthy rats with either of 2 structurally and mechanistically distinct inhibitors of H 2 S synthesis resulted in significant colonic inflammation suggests that H 2 S plays an important role as a tonic antiinflammatory substance in the mucosa.
An increase in colonic H 2 S synthesis in samples of inflamed colon was detectable only when exogenous Lcysteine was added to the reaction mixture. This raises the possibility that tissue L-cysteine levels may "regulate" colonic H 2 S synthesis, at least in the context of inflammation. However, this requires further investigation.
In summary, the present studies provide evidence that both endogenous and exogenous H 2 S can promote the resolution of experimental colitis. The contribution of bacterially derived H 2 S in a setting of colitis remains unclear. These findings may have important implications for the therapy of IBD.
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Note: To access the supplementary material accompanying this article, visit the online version of Figure 8 . Effects of twice-daily intracolonic treatment with an H 2 S donor (NaHS or Lawesson's reagent; each at 30 mol/kg) on severity of colitis. Treatment was started 1 hour after induction of colitis and continued for 4 days. Two hours after the final dose of the test drugs, the rats were killed, and the severity of colonic damage and change in thickness of the colon were blindly evaluated. TNF-␣ mRNA expression was evaluated in samples of colonic tissue taken after evaluation of the colonic injury (expressed as fold increase over that in healthy rats). *P Ͻ .05 vs the vehicle-treated group (n ϭ 5-8 per group).
